Extracting a needle from a haystack: Reanalysis of whole genome data reveals a readily translatable finding

Psychological Medicine

Volumn 39, Issue 8, 2009, Pages 1231-1235

  Keers, R ^a   Farmer, A E ^a   Aitchison, K J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bipolar disorder; Cav1.2; CACNA1C; Calcium channel blockers; Dihydropyridine; Genetic predisposition to disease

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; AMLODIPINE; ANTIHISTAMINIC AGENT; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL STIMULATING AGENT; DESIPRAMINE; DILTIAZEM; DOPAMINE RECEPTOR BLOCKING AGENT; FELODIPINE; FLUNARIZINE; IMIPRAMINE; ISRADIPINE; LITHIUM; NEUROLEPTIC AGENT; NICARDIPINE; NIFEDIPINE; NIMODIPINE; VERAPAMIL;

ALPHA CHAIN; BIPOLAR DISORDER; CACNA1C GENE; CALCIUM CHANNELOPATHY; CENTRAL NERVOUS SYSTEM; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENE; GENETIC ASSOCIATION; GENOME; GENOME ANALYSIS; HUMAN; MAJOR DEPRESSION; MIGRAINE; MOOD DISORDER; NONHUMAN; PHARMACOGENETICS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; FLUNARIZINE; GENE FREQUENCY; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MICE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 69549136904     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291708005084     Document Type: Review

References (30)

1. Amery WK (1983). Flunarizine, a calcium channel blocker : a new prophylactic drug in migraine. Headache 23, 70-74. (Pubitemid 13165420)
2. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nothen MM, Georgi A, Schumacher J, Schwarz M, Abou JR, Hofels S, Propping P, Satagopan J, tera-Wadleigh SD, Hardy J, McMahon FJ (2008). A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Molecular Psychiatry 13, 197-207.
3. Brunet G, Cerlich B, Robert P, Dumas S, Souetre E, Darcourt G (1990). Open trial of a calcium-antagonist, nimodipine, in acute mania. Clinical Neuropharmacology 13, 224-228. (Pubitemid 20181213)
4. De Beaurepaire R (1992). Treatment of neuroleptic-resistant mania and schizoaffective disorders. American Journal Psychiatry 149, 1614-1615.
5. Detera-Wadleigh SD, Barden N, Craddock N, Ewald H, Foroud T, Kelsoe J, McQuillin A (1999). Chromosomes 12 and 16 workshop. American Journal of Medical Genetics 88, 255-259.
6. DiMasi JA, Hansen RW, Grabowski HG (2003). The price of innovation : new estimates of drug development costs. Journal of Health Economics 22, 151-185.
7. Dubovsky SL, Thomas M, Hijazi A, Murphy J (1994). Intracellular calcium signaling in peripheral cells of patients with bipolar affective-disorder. European Archives of Psychiatry and Clinical Neuroscience 243, 229-234. (Pubitemid 24083875)
8. Ettinger AB, Reed ML, Goldberg JF, Hirschfeld RMA (2005). Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology 65, 535-540.
9. Gargus JJ (2006). Ion channel functional candidate genes in multigenic neuropsychiatric disease. Biological Psychiatry 60, 177-185.
10. Garzatrevino ES, Overall JE, Hollister LE (1992). Verapamil versus lithium in acute mania. American Journal of Psychiatry 149, 121-122.
11. Gitlin MJ, Swendsen J, Heller TL, Hammen C (1995). Relapse and impairment in bipolar disorder. American Journal of Psychiatry 152, 1635-1640.
12. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB (2002). The long-term natural history of the weekly symptomatic status of bipolar I disorder. Archives of General Psychiatry 59, 530-537. (Pubitemid 34602935)
13. Kato T (2007). Molecular genetics of bipolar disorder and depression. Psychiatry and Clinical Neuroscience 61, 3-19. (Pubitemid 46089400)
14. Levy NA, Janicak PG (2000). Calcium channel antagonists for the treatment of bipolar disorder. Bipolar Disorders 2, 108-119.
15. Licht RW (1998). Drug treatment of mania: a critical review. Acta Psychiatrica Scandinavica 97, 387-397. (Pubitemid 28270783)
16. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A (2003). The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Archives of General Psychiatry 60, 497-502. (Pubitemid 36539059)
17. Mogilnicka E, Czyrak A, Maj J (1988). Bay-K-8644 enhances immobility in the mouse behavioral despair test, an effect blocked by nifedipine. European Journal of Pharmacology 151, 307-311. (Pubitemid 18176935)
18. Mulley JC, Scheffer IE, Petrou S, Berkovic SF (2003). Channelopathies as a genetic cause of epilepsy. Current Opinion in Neurology 16, 171-176.
19. 2+ channel gene CACNL1A4. Cell 87, 543-552.
20. Pazzaglia PJ, Post RM, Ketter TA, Callahan AM, Marangell LB, Frye MA, George MS, Kimbrell TA, Leverich GS, Cora-Locatelli G, Luckenbaugh D (1998). Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness. Journal of Clinical Psychopharmacology 18, 404-413. (Pubitemid 28462631)
21. Pazzaglia PJ, Post RM, Ketter TA, George MS, Marangell LB (1993). Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation. Psychiatry Research 49, 257-272.
22. Radat F, Swendsen J (2005). Psychiatric comorbidity in migraine : a review. Cephalalgia 25, 165-178.
23. Sheftell FD, Atlas SJ (2002). Migraine and psychiatric comorbidity : from theory and hypotheses to clinical application. Headache 42, 934-944.
24. Silberstein D, Goadsby PJ (2002). Migraine : preventive treatment. Cephalalgia 22, 491-512.
25. Sinnegger-Brauns MJ, Hetzenauer A, Huber IG, Renstrom E, Wietzorrek G, Berjukov S, Cavalli M, Walter D, Koschak A, Waldschutz R, Hering S, Bova S, Rorsman P, Pongs O, Singewald N, Striessnig J (2004). Isoform-specific regulation of mood behavior and pancreatic beta cell and cardiovascular function by L-type Ca2+ channels. Journal of Clinical Investigation 113, 1430-1439. (Pubitemid 39071698)
26. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, Craddock N, DePaulo JR, Lander ES (2002). Family-based association study of 76 candidate genes in bipolar disorder : BDNF is a potential risk locus. Molecular Psychiatry 7, 579-593. (Pubitemid 34888421)
27. Sklar P, Smoller JW, Fan J, Ferreira MAR, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PIW, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH, Gurling HM, Purcell SM (2008). Whole-genome association study of bipolar disorder. Molecular Psychiatry 13, 558-569. (Pubitemid 351704939)
28. Triggle D (1992). Biochemical and pharmacologic differences among calcium channel antagonists : clinical implications. In Calcium Antagonists in Clinical Medicine (ed. M. Epstein), pp. 1-27. Hanley & Belfus : Philadelphia.
29. Wei J, Hemmings GP (2006). A further study of a possible locus for schizophrenia on the X chromosome. Biochemical and Biophysical Research Communications 344, 1241-1245.
30. Wellcome Trust Case Control Consortium (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678.